Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The mutation rate and cancer

A L Jackson1, L A Loeb

  • 1Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington, Seattle 98195, USA.

Genetics
|April 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices.

Gynecologic oncology·2024
Same author

Interventions to Support Children's Recovery From Neglect-A Systematic Review.

Child maltreatment·2023
Same author

Small Talk: Identifying communication problems in maltreated children.

Child abuse & neglect·2017
Same author

Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

Children and youth selected health characteristics, United States - 1958 and 1968.

Vital and health statistics. Series 10, Data from the National Health Survey·2014
Same author

Effects of natural antimicrobials on inhibition of Listeria monocytogenes and on chemical, physical and sensory attributes of naturally-cured frankfurters.

Meat science·2011
Same journal

Coexistence of piRNA and KZFP defense systems: Evolutionary dynamics of layered defense against transposable elements.

Genetics·2026
Same journal

Creation and manipulation of bipartite expression transgenes in C. elegans using phiC31 recombinase.

Genetics·2026
Same journal

Inherited long telomeres induce a genome-wide transcriptional response in budding yeast.

Genetics·2026
Same journal

Adaptive Dynamics of Quantitative Traits in a Steadily Changing Environment.

Genetics·2026
Same journal

Functional Landscape of Zebrafish Gonadotropins and Receptors: A Comprehensive Genetic Analysis.

Genetics·2026
Same journal

Synergistic actions of Nup43 and Myosin VI drive actin cone assembly during Drosophila spermiogenesis.

Genetics·2026
See all related articles

Germline mutations are rare, but somatic mutation rates may increase in cancer. Understanding the origins and impact of these mutations is key to tumor progression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • The human genome's stability relies on rare germline mutations.
  • While most mutations are neutral or harmful, some drive adaptation.
  • Microbial DNA mutation rates are approximately 0.003 per genome per replication, unlike RNA viruses with higher rates.

Purpose of the Study:

  • To review somatic mutations in cancer.
  • To explore the potential increase in somatic mutation rates during cancer development.
  • To investigate the origins and significance of mutations in tumor progression.

Main Methods:

  • Literature review of mutation rates in DNA-based microbes and RNA viruses.
  • Discussion of germline versus somatic mutation rate constancy.

Related Experiment Videos

  • Examination of mutation 'hot-spots' within the eukaryotic genome.

    • Main Results:

    • Somatic mutation rates may not be constant during development.
    • Cancer is associated with an apparent increase in somatic mutations genome-wide.
    • Tumors can harbor thousands of DNA sequence changes, with specific hot-spots.

    Conclusions:

    • The rate of somatic mutations can vary, particularly in cancer.
    • Further research is needed to understand how mutations arise in tumors.
    • Determining the rate-limiting role of mutations in tumor progression is a critical question.